Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
IndustryJuly 1, 2026

Four Chemotherapy Drugs Remain in Shortage Until October

Cisplatin, carboplatin, oxaliplatin, and ifosfamide remain in active shortage, with full resupply of some formulations not expected until October 2026, according to the American Society of Health-System Pharmacists. These chemotherapy drugs are essential for treating breast, lung, ovarian, testicular, bladder, and head and neck cancers. Manufacturers have provided updated timelines for when supply will normalize. The shortages affect hospitals and health systems managing cancer treatment protocols.

Why it mattersMedicaid managed care organizations covering oncology services must work with network providers to manage formulary alternatives, prior authorization protocols, and care coordination for members requiring these chemotherapy agents during the shortage period.

Managed Care · Pharmacy

Read the full article at beckershospitalreview.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.